"PAI is a market leader in RTU oral liquid medicines, and that same focus on quality, reliability, and patient-centric design carries naturally into RTU injectables," said Kurt Orlofski, CEO of PAI ...

RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and ...

Sharp Sterile Manufacturing is investing $28 million to expand its site in Lee, Massachusetts, which offers a range of ...

The US Food and Drug Administration (USFDA) recorded a significant decline in serious regulatory findings at Indian drug ...

Daiichi Sankyo plans to splash out some 300 billion yen ($1.9 billion) on Enhertu manufacturing facilities across the globe, ...

Alnylam Pharmaceuticals has announced a $250 million investment to expand its manufacturing facility in Massachusetts. The ...

An India-headquartered global biopharmaceutical company is making a big bet on the Garden State. Biocon Ltd. focuses on enhancing affordable access to complex therapies for chronic conditions, such as ...

In line with the Trump administration’s goal to curb the U.S.’ reliance on overseas drug manufacturing, the FDA has deployed a new program designed to take some of the headache out of setting up ...

Headquartered in Greenville, South Carolina, PAI is a developer, manufacturer and marketer of oral liquid medicines.

Pharmaceutical companies AstraZeneca and Eli Lilly & Co. are planning to locate major manufacturing facilities in Albemarle and Goochland counties respectively, a state official has confirmed. Last ...

A top executive from Sigachi Industries was arrested over a deadly explosion at the company's pharmaceutical plant in ...